0000899243-22-016532.txt : 20220504
0000899243-22-016532.hdr.sgml : 20220504
20220504070020
ACCESSION NUMBER: 0000899243-22-016532
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220502
FILED AS OF DATE: 20220504
DATE AS OF CHANGE: 20220504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Magovcevic-Liebisch Ivana
CENTRAL INDEX KEY: 0001279281
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41200
FILM NUMBER: 22889768
MAIL ADDRESS:
STREET 1: 300 TECHNOLOGY SQUARE
STREET 2: 8TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER NAME:
FORMER CONFORMED NAME: Magovcevic Ivana
DATE OF NAME CHANGE: 20040503
FORMER NAME:
FORMER CONFORMED NAME: MARAVIC MAGOVCEVIC IVANA
DATE OF NAME CHANGE: 20040209
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vigil Neuroscience, Inc.
CENTRAL INDEX KEY: 0001827087
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 TECHNOLOGY SQUARE
STREET 2: 10TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-254-4445
MAIL ADDRESS:
STREET 1: 400 TECHNOLOGY SQUARE
STREET 2: 10TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-02
0
0001827087
Vigil Neuroscience, Inc.
VIGL
0001279281
Magovcevic-Liebisch Ivana
VIGIL NEUROSCIENCE, INC.
1 BROADWAY, 7TH FLOOR, SUITE 07-300
CAMBRIDGE
MA
02142
1
1
0
0
President and CEO
Common Stock
2022-05-02
4
P
0
4000
3.6097
A
202687
D
Common Stock
2022-05-03
4
P
0
1000
3.9402
A
203687
D
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.27 to $3.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.89 to $4.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.
/s/ Jennifer Ziolkowski, Attorney-in-Fact
2022-05-04